E

EyePoint Pharmaceuticals

D
EYPT
USD
-0.21
(-1.8166%)
Market Open
2,726.00
Volume
-2.09
EPS
-
Div Yield
-6.426966
P/E
612,248,322.40
Market Cap
Today
-1.0381%
1 Week
-2.886%
1 Month
31.042%
6 Months
-3.623%
12 Months
49.347%
Year To Date
-50.455%
All Time
0%

Title:
EyePoint Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Do you need help or have a question?